These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8230098)

  • 1. A series of penicillin derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships.
    Humber DC; Bamford MJ; Bethell RC; Cammack N; Cobley K; Evans DN; Gray NM; Hann MM; Orr DC; Saunders J
    J Med Chem; 1993 Oct; 36(21):3120-8. PubMed ID: 8230098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A series of penicillin-derived C2-symmetric inhibitors of HIV-1 proteinase: structural and modeling studies.
    Wonacott A; Cooke R; Hayes FR; Hann MM; Jhoti H; McMeekin P; Mistry A; Murray-Rust P; Singh OM; Weir MP
    J Med Chem; 1993 Oct; 36(21):3113-9. PubMed ID: 8230097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.
    Holmes DS; Bethell RC; Cammack N; Clemens IR; Kitchin J; McMeekin P; Mo CL; Orr DC; Patel B; Paternoster IL
    J Med Chem; 1993 Oct; 36(21):3129-36. PubMed ID: 8230099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors: heterocyclic ring systems containing P1' and P2' substituents.
    Kitchin J; Bethell RC; Cammack N; Dolan S; Evans DN; Holman S; Holmes DS; McMeekin P; Mo CL; Nieland N
    J Med Chem; 1994 Oct; 37(22):3707-16. PubMed ID: 7966131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.
    Barrish JC; Gordon E; Alam M; Lin PF; Bisacchi GS; Chen P; Cheng PT; Fritz AW; Greytok JA; Hermsmeier MA
    J Med Chem; 1994 Jun; 37(12):1758-68. PubMed ID: 8021916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibitors of the HIV-1 protease with good oral bioavailabilities.
    Sham HL; Zhao C; Marsh KC; Betebenner DA; Lin S; McDonald E; Vasavanonda S; Wideburg N; Saldivar A; Robins T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):159-65. PubMed ID: 7779082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and analysis of a series of C2-symmetric HIV-1 proteinase inhibitors derived from penicillin.
    Gray NM; Cameron JM; Cammack N; Cobley KN; Holmes DS; Humber DC; Orr DC; Penn CR; Potter R; Madar S
    Anal Biochem; 1994 Jan; 216(1):89-96. PubMed ID: 8135370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of HIV-1 protease.
    Jhoti H; Singh OM; Weir MP; Cooke R; Murray-Rust P; Wonacott A
    Biochemistry; 1994 Jul; 33(28):8417-27. PubMed ID: 8031777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
    Fässler A; Bold G; Capraro HG; Cozens R; Mestan J; Poncioni B; Rösel J; Tintelnot-Blomley M; Lang M
    J Med Chem; 1996 Aug; 39(16):3203-16. PubMed ID: 8759643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.
    Kiso Y
    Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease.
    Kempf DJ; Marsh KC; Paul DA; Knigge MF; Norbeck DW; Kohlbrenner WE; Codacovi L; Vasavanonda S; Bryant P; Wang XC
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2209-14. PubMed ID: 1803993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
    Bouzide A; Sauvé G; Yelle J
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1509-13. PubMed ID: 15713418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
    Kempf DJ; Marsh KC; Denissen JF; McDonald E; Vasavanonda S; Flentge CA; Green BE; Fino L; Park CH; Kong XP
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2484-8. PubMed ID: 7708670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.
    Tucker TJ; Lumma WC; Payne LS; Wai JM; de Solms SJ; Giuliani EA; Darke PL; Heimbach JC; Zugay JA; Schleif WA
    J Med Chem; 1992 Jul; 35(14):2525-33. PubMed ID: 1635054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors.
    Dorsey BD; McDonough C; McDaniel SL; Levin RB; Newton CL; Hoffman JM; Darke PL; Zugay-Murphy JA; Emini EA; Schleif WA; Olsen DB; Stahlhut MW; Rutkowski CA; Kuo LC; Lin JH; Chen IW; Michelson SR; Holloway MK; Huff JR; Vacca JP
    J Med Chem; 2000 Sep; 43(18):3386-99. PubMed ID: 10978186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of potent and orally active HIV-protease inhibitors.
    Capraro HG; Bold G; Fässler A; Cozens R; Klimkait T; Lazdins J; Mestan J; Poncioni B; Rösel JL; Stover D; Lang M
    Arch Pharm (Weinheim); 1996 Jun; 329(6):273-8. PubMed ID: 8767110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase.
    Ettmayer P; Billich A; Hecht P; Rosenwirth B; Gstach H
    J Med Chem; 1996 Aug; 39(17):3291-9. PubMed ID: 8765512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.
    Melnick M; Reich SH; Lewis KK; Mitchell LJ; Nguyen D; Trippe AJ; Dawson H; Davies JF; Appelt K; Wu BW; Musick L; Gehlhaar DK; Webber S; Shetty B; Kosa M; Kahil D; Andrada D
    J Med Chem; 1996 Jul; 39(14):2795-811. PubMed ID: 8709110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
    Mahalingam AK; Axelsson L; Ekegren JK; Wannberg J; Kihlström J; Unge T; Wallberg H; Samuelsson B; Larhed M; Hallberg A
    J Med Chem; 2010 Jan; 53(2):607-15. PubMed ID: 19961222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains.
    Wannberg J; Sabnis YA; Vrang L; Samuelsson B; Karlén A; Hallberg A; Larhed M
    Bioorg Med Chem; 2006 Aug; 14(15):5303-15. PubMed ID: 16621572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.